Cargando…

Botulinum Toxin Therapy for Psychiatric Disorders in Clinical Practice: A Retrospective Case Study

Inhibiting the facial expression of negative emotions via botulinum toxin A (BTX) has been shown to mitigate symptoms of clinical depression in randomized controlled trials. This retrospective case study sought to reproduce the beneficial effects of BTX in a naturalistic setting for major depressive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lehnert, Franziska, Neumann, Insa, Krüger, Tillmann H. C., Wollmer, Marc A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301237/ https://www.ncbi.nlm.nih.gov/pubmed/37368686 http://dx.doi.org/10.3390/toxins15060385

Ejemplares similares

Treatment of Depression with Botulinum Toxin
por: Wollmer, Marc Axel, et al.
Publicado: (2022)

Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety
por: Wollmer, M. Axel, et al.
Publicado: (2021)

Neuronal effects of glabellar botulinum toxin injections using a valenced inhibition task in borderline personality disorder
por: Kruger, Tillmann H. C., et al.
Publicado: (2022)

Agitation Predicts Response of Depression to Botulinum Toxin Treatment in a Randomized Controlled Trial
por: Wollmer, M. Axel, et al.
Publicado: (2014)

Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites
por: Makunts, Tigran, et al.
Publicado: (2020)

Use of Botulinum Toxin in Orofacial Clinical Practice
por: Serrera-Figallo, Maria-Angeles, et al.
Publicado: (2020)

Botulinum toxin therapy: functional silencing of salivary disorders
por: Lovato, A., et al.
Publicado: (2017)

Botulinum toxin therapy of dystonia
por: Dressler, Dirk, et al.
Publicado: (2020)

Use of botulinum toxin for movement disorders
por: Camargo, Carlos Henrique Ferreira, et al.
Publicado: (2019)

Botulinum Toxin in Movement Disorders: An Update
por: Anandan, Charenya, et al.
Publicado: (2021)

Economics of botulinum toxin therapy: influence of the abobotulinumtoxinA package size on the costs of botulinum toxin therapy
por: Dressler, Dirk, et al.
Publicado: (2017)

BOTULINUM TOXIN
por: Nigam, P K, et al.
Publicado: (2010)

Botulinum Toxin Therapy in Congenital Blepharospasm
por: Wabbels, Bettina
Publicado: (2014)

History of Botulinum Toxin Treatment in Movement Disorders
por: Jabbari, Bahman
Publicado: (2016)

Experiences on The Administration of Botulinum Toxin in Movement Disorders
por: Tuğan Yıldız, Buket, et al.
Publicado: (2021)

The Development of Psychiatric Illness and Chemoprophylaxis of Botulinum Toxin in Migraine: A Narrative Review
por: Dhengare, Ayushi S, et al.
Publicado: (2022)

Best Clinical Practice in Botulinum Toxin Treatment for Children with Cerebral Palsy
por: Strobl, Walter, et al.
Publicado: (2015)

Clinical Relevance of Botulinum Toxin Immunogenicity
por: Benecke, Reiner
Publicado: (2012)

Botulinum toxin type A treatment to the upper face: retrospective analysis of daily practice
por: Prager, Welf, et al.
Publicado: (2012)

Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System
por: Yoshida, Kazuya
Publicado: (2022)

Headache and botulinum toxin
por: Porta, M., et al.
Publicado: (2005)

Immunogenicity of botulinum toxins
por: Naumann, Markus, et al.
Publicado: (2012)

Diffusion of Botulinum Toxins
por: Brodsky, Matthew A., et al.
Publicado: (2012)

Immunogenicity of botulinum toxin
por: Wee, Syeo Young, et al.
Publicado: (2022)

Guidelines for the use of botulinum toxin in movement disorders and spasticity
por: Jabeen, Afshan, et al.
Publicado: (2011)

Botulinum Toxin Type A Therapy in Migraine: Preclinical and Clinical Trials
por: Shao, Yu-Feng, et al.
Publicado: (2013)

Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin
por: Contarino, Maria Fiorella, et al.
Publicado: (2017)

Clinical Application of Botulinum Toxin for Hemifacial Spasm
por: Park, Chang-Kyu, et al.
Publicado: (2023)

A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatment
por: Kim, Hyun-Suk, et al.
Publicado: (2016)

Toxin yet not toxic: Botulinum toxin in dentistry
por: Archana, M.S.
Publicado: (2016)

Impact of Disrupted Botulinum Toxin Therapy in Movement Disorders Due to COVID-19 Pandemic
por: Neeraja, Koti, et al.
Publicado: (2021)

Botulinum toxin antibody titres: measurement, interpretation, and practical recommendations
por: Dressler, Dirk, et al.
Publicado: (2022)

Botulinum Toxin Therapy for Cervical Dystonia: The Science of Dosing
por: Evidente, Virgilio Gerald H., et al.
Publicado: (2014)

Postsurgical Refractory Gastroparesis: Response to Botulinum Toxin Therapy
por: Sarvepalli, Deepika, et al.
Publicado: (2020)

Botulinum toxin in cancer therapy—current perspectives and limitations
por: Grenda, Tomasz, et al.
Publicado: (2021)

Botulinum Toxin Therapy in Writer’s Cramp and Musician’s Dystonia
por: Zakin, Elina, et al.
Publicado: (2021)

Botulinum toxin therapy: past, present and future developments
por: Dressler, Dirk, et al.
Publicado: (2022)

Time to onset and duration of botulinum toxin efficacy in movement disorders
por: Ledda, Claudia, et al.
Publicado: (2022)

Controversy: Botulinum Toxin in Pregnancy
por: Paul, Munish
Publicado: (2009)

Botulinum toxin: The Midas touch
por: Shilpa, P. S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c6hitv8nv5kc7nb26qnkqv8049